European Commission logo
français français
CORDIS - Résultats de la recherche de l’UE
CORDIS

JPIAMR- ANTIMICROBIAL TRANSMISSION INTERVENTIONS

Description du projet

Lutter contre la menace sanitaire de la résistance aux antimicrobiens

La résistance aux antimicrobiens (RAM) est un grave problème qui menace l’efficacité de la prévention et du traitement d’une série d’infections à travers le monde. Pour lutter contre ce problème, le projet JPIAMR-ACTION, financé par l’UE et cofinancé par ERA-NET, soutiendra la recherche et l’innovation afin de développer des stratégies et des méthodologies qui réduiront la transmission et la propagation de la RAM dans le cadre d’une approche «Une seule santé». L’appel cofinancé par JPIAMR-ACTION, qui vise notamment à mettre en lumière l’impact des interventions sur le développement et la transmission de la résistance aux antibiotiques, est essentiel pour atteindre cet objectif. Cet appel, ainsi que d’autres activités, permettra d’élaborer de nouvelles approches et d’améliorer les actions existantes, en vue d’interventions qui mettront un terme à la RAM chez les humains, chez les animaux et dans l’environnement.

Objectif

In the past 90 years since their discovery, antibiotics have saved millions of lives from bacterial diseases. However, emerging resistance to antimicrobials now threatens many advances achieved in modern medicine. AMR is a critical global health issue tightly linked with the One Health concept, which recognises that human and animal health are inextricably linked, and that diseases are transmitted from humans to animals and vice versa. One Health also encompasses the environment as another link between humans and animals and a potential source and reservoir of AMR. Antimicrobial resistance is a growing global health concern and threatens the future treatment and health of humans and animals. In addition, AMR limits our ability to achieve several of the UN Sustainable Development Goals (SDGs). The global challenge to address AMR goes beyond the production of new antibiotics and therapies. Reducing demand for new antibiotics through public awareness, infection prevention and control, prudent and rational use of antibiotics for humans and animals, as well as effective diagnosis and surveillance of antibiotic-resistant infections and monitoring antibiotic use, are crucial when dealing with this problem globally. The transmission and spread of AMR in and between One Health compartments is complex, which emphasises the need for comprehensive interventions to reverse the trend of increasing human and animal infections resistant to treatment. The ERA-NET Cofund JPIAMR-ACTION will tackle this central challenge by supporting research and innovation for the development and testing of strategies and methodologies to reduce the transmission and spread of AMR within a full One Health spectrum. The JPIAMR-ACTION co-funded call and other activities will be instrumental in producing new innovative approaches, and advancing existing actions towards the development of new and improved interventions to inhibit or limit the development of AMR in humans, animals and the environment.

Appel à propositions

H2020-SC1-BHC-2018-2020

Voir d’autres projets de cet appel

Sous appel

H2020-SC1-2020-Single-Stage-RTD

Régime de financement

ERA-NET-Cofund - ERA-NET Cofund

Coordinateur

VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL
Contribution nette de l'UE
€ 1 049 812,50
Adresse
BOX 1035
101 38 Stockholm
Suède

Voir sur la carte

Région
Östra Sverige Stockholm Stockholms län
Type d’activité
Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Liens
Coût total
€ 3 181 250,00

Participants (25)